Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.140
-0.060 (-1.43%)
At close: Aug 27, 2026, 4:00 PM EDT
4.150
+0.010 (0.24%)
After-hours: Aug 27, 2026, 7:30 PM EDT
Camp4 Therapeutics Market Cap
Camp4 Therapeutics has a market cap or net worth of $259.8 million as of August 27, 2026. Its market cap has increased by 742.23% in one year.
Market Cap
259.80M
Enterprise Value
175.77M
1-Year Change
742.23%
Ranking
Category
Stock Price
$4.14
ChartMarket Cap Chart
Since the IPO on October 11, 2024, Camp4 Therapeutics's market cap has increased from $208.55M to $259.80M, an increase of 24.57%. That is a compound annual growth rate of 12.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 259.80M | -18.31% |
| Dec 31, 2025 | 318.03M | 202.65% |
| Dec 31, 2024 | 105.08M | -49.61% |
| Oct 11, 2024 | 208.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Whitehawk Therapeutics | 289.61M |
| Lineage Cell Therapeutics | 285.79M |
| Sionna Therapeutics | 282.58M |
| Eledon Pharmaceuticals | 282.25M |
| Neumora Therapeutics | 281.84M |
| Invivyd | 276.69M |
| ALX Oncology Holdings | 276.55M |
| Entrada Therapeutics | 274.75M |